Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2119-2125

  Zheng, Ye ^c   Kramer, Paula M ^c   Olson, Greg ^a   Lubet, Ronald A ^b   Steele, Vernon E ^b   Kelloff, Gary J ^b   Pereira, Michael A ^c  

^a Pathology Associates Inc   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; AZOXYMETHANE; CYCLINE; FENRETINIDE; RETINOID; TEMAROTENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; CELL DIVISION; COLONIC NEOPLASMS; FENRETINIDE; MALE; PRECANCEROUS CONDITIONS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; TRETINOIN;

EID: 0031431888     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2119     Document Type: Article

References (44)

1. Boone, C.W., Kelloff, G.J. and Malone, W.E. (1990) Identification of candidate cancer chemopreventive agents and their evolution in animal models and human clinical trials: a review. Cancer Res., 50, 2-9.
2. Boone, C.W., Kelloff, G.J. and Steel, V.E. (1992) Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res., 52, 1651-1659.
3. Sporn, M.B. and Newton, D.L. (1979) Chemoprevention of cancer with retinoids. Fedn Proc., 38, 2528-2534.
4. Steele, V.E. et al. (1994) Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI chemoprevention drug development program. J. Cell. Biochem., 20, 32-54.
5. Strickland, S. and Mahadavi, V. (1978) The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 15, 393-403.
6. Sporn, M.B. and Roberts, A.B. (1991) Interactions of retinoids and transforming growth factor-beta in regulation of cell differentiation and proliferation. Mol. Endocrinol., 5, 3-7.
7. Shekelle, R.B., Lepper, M., Liu, S., Maliza, C., Raymor, W.J., Rossof, A.H., Paul, O., Shryock, A.M. and Stamler, J. (1981) Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet, ii, 1186-1190.
8. Castaigne, S., Chomienne C., Daniel, M.T., Fenaux, P. Berger, R. and Degosi, L. (1990) All-trans-retinoic acid as a differentiation therapy in acute promyelocytic leukemias. I. Clinical results. Blood, 76, 1704-9.
9. Warrel, R.P., Jr et al. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New Engl. J. Med., 324, 1385.
10. Hong, W.K. et al. (1990) Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. New Engl. J. Med., 323, 795-801.
11. Silverman, J., Katayama, S., Zelenakas, K., Lauber, J., Musser, T.K., Reddy, M., Levenstein, M.J. and Weisburger, J.H. (1981) Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosourea or by 1,2-dimethylhydrazine. Carcinogenesis, 2, 1167-1172.
12. Mathe, G. et al. (1982) Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoids treatment. Cancer Detect. Prevent., 5, 461-166.
13. Dawson, M.I., Chao, W.R. and Helmes, L.T. (1987) Inhibition by retinoids of anthralin induced mouse epidermal ornithine decarboxylase activity and anthralin-promoted skin tumor formation. Cancer Res., 47, 6210-6215.
14. Baba, M., Iishi, H., Yamamoto, R. and Tatsuta, M. (1991) Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of expression of myc oncogene protein in Sprague-Dawley rats. Int. J. Cancer, 49, 467-470.
15. Pollard, M., Luckert, P.H. and Sporn, M.D. (1991) Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res., 51, 3610-3611.
16. Moon, R.C. et al. (1979) N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res., 39, 1339-1346.
17. Bird, R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
18. Pretlow, T.P., Cheter, C. and O'Riordan, M.A. (1994) Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int. J. Cancer, 56, 599-602.
19. Pretlow, T.P., O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512.
20. Wargovich, M.J., Chen, C.D., Harris, C., Yang, E. and Velasco, M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-imflammatory agents and differentiation agents in the rat colon. Int. J. Cancer, 60, 515-519.
21. Pereira, M.A. and Khoury, M.D. (1991) Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett., 61, 27-33.
22. Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.V., Steele, V.E. and Lubet, R.A. (1994). Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054.
23. Stopera, S.A. and Bird, R.P. (1993) Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: differential expression of c-myc and c-fos mRNA and protein. Int. J. Cancer, 53, 798-804.
24. Bird, R.P. (1987) Observations and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151.
25. McLellan, E.A., Medline, A. and Bird, R.P. (1991) Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51, 5270-5274.
26. Pretlow, T.P., O'Riordan, M.A., Pretlow, T.G. and Stellato, T.A. (1992) Aberrant crypts in human colonic mucosa: putative preneoplastic lesion. J. Cell. Biochem., 16G (suppl.), 55-62.
27. Pretlow, T.P., Barrow, B.J., Ashton, W.S., O'Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
28. Roncucci, L., Stamp, D., Medline, A., Cullen, J.B. and Bruce, W.R. (1991) Identification of quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol., 22, 287-294.
29. 3 thymidine incorporation in mucosa of multiple polyposis. J. Clin. Invest., 42, 1922-1928.
30. Deschner, E.E. and Lipkin, M. (1975) Proliferative patterns in colonic mucosa in familial polyposis. Cancer, 35, 413-118.
31. Scalmati, A. and Lipkin, M. (1993) Proliferation and differentiation biomarkers in colorectal mucosa and their application to chemoprevention studies. Environ. Hlth Perspect., 99, 169-173.
32. Kelloff, G.J., Boone, C.W., Steele, V.E., Fay, J.R., Lubet, R.A., Crowell, J.A. and Sigman, C.C. (1994) Mechanistic considerations in chemopreventive drug development. J. Cell. Biochem., 20 (suppl.), 1-24.
33. Greenwald, P., Kelloff, G.J., Boone, C.W. and McDonald, S.S. (1995) Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol. Biomarkers Prevent., 4, 691-702.
34. Elwell, J.R. and McConnell, E.E. (1994) Small and large intestine. In Boorman, G.A., Eustis, S.L., Elwell, M.R., Montgomery, C.A. and MacKenzie, W.F. (eds), Pathology of the Fischer Rat. Academic Press, San Diego, CA, pp. 43-61.
35. Ward, J.M., Sporn, M.B., Wenk, M.L., Smith, J.M., Feeser, D. and Dean, R.J. (1978) Dose response to intrarectal administration of N-methyl-N-nitrosourea and histpathologic evaluation of the effect of two retinoids on colon lesions induced in rats. J. Natl Cancer Inst., 60, 1489-1493.
36. Wenk, M.L., Ward, J.M., Reznik, G. and Dean, J. (1981) Effects of three retinoids on colon adenocarcinomas, sarcomas, and hyperplastic polyps induced by intrarectal N-methyl-N-nitrosourea administered in male F344 rats. Carcinogenesis, 2, 1161-1166.
37. Lipkin, M., Blattner, W.A., Fraumeni, J.F., Jr, Lynch, H.T., Deschner, E.E. and Winawer, S. (1983) Tritiated thymidine labeling distribution as a marker for heredity predisposition to colon cancer. Cancer Res., 43, 1899-1904.
38. 3H]dThd-labeling patterns in colonic epithelial cells. Cancer Res., 44, 4201-4207.
39. Martin, C.A., Ziegler, L.M. and Napoli, J.L. (1990) Enhanced expression of c-fos is not obligatory for retinoic acid-induced F9 cell differentiation. Mol. Cell. Endocrinol., 71, 27-31.
40. Miller, W.H., Moy, D., Li, A., Grippo, J.F. and Dmitrovsky, E. (1990) Retinoic acid induces down-regulation of several growth factors and protooncogenes in a human embryonal cell line. Oncogene, 5, 511-517.
41. Baba, M., Iishi, H., Yamamoto, R. and Tatsuta, M. (1991) Inhibition by retinoic acid of hepatocarcinogenesis induced by N-nitrosomorpholine and of the expression of c-myc oncogene protein in Sprague-Dawley rats. Int. J. Cancer, 49, 467-470.
42. Mangelsdorf, D.J., Umesono, K. and Evans, R.M. (1994) The retinoid receptors. In Sporn, M.B., Roberts, A.B. and Goodman, D.S. (eds). The Retinoids: Biology, Chemistry and Medicine, Raven Press, New York, NY, pp. 319-349.
43. Sheikh, M.S. et al. (1995) N-(4-Hdroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis, 16, 2477-2486.
44. Oridate, N., Lotan, D., Mitchell, M.F., Hong, W.K. and Lotan, R. (1995) Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implication for chemoprevention. J. Cell. Biochem., 23 (suppl.), 80-86.